The countdown to MIDD+ 2022 continues!
Watch the video to hear Neil Miller discuss the importance of preclinical verification of a PBPK model in a First in Human PBPK prediction presented last year.
Sign up for Neil’s FIH workshop after the MIDD+ conference.

California

Simulations Plus

• Upcoming GastroPlus Workshops
  • PBPK Modeling for FIH Predictions – Feb. 21- March 18
  • Complimentary Introduction to GastroPlus® – March 1
  • Introductory Workshop – March 7-11
• University+ Academic Webinar Series
  • PBPK Model in Special Populations with Rodrigo Cristofoletti from the University of Florida, Wednesday, February 23rd
  • GastroPlus Academic Webinar Series with Gabriel Lima Barros de Araujo from the University of Sao Paulo, Wednesday, March 16th
• MembranePlus v3 is coming soon! Here are 3 exciting enhancements:
  • New models of in vitro penetration (IVPT) and release (IVRT) tests for transdermal formulations for novel analysis of absorption and dissolution kinetics
  • Expanded membrane transport model parameters for improved predictions of permeability coefficients for both small and peptide molecules
  • Improved data handling and simulation performance

View All Workshops

New York

Cognigen

Early in the COVID-19 pandemic, Merck and the Cognigen division of Simulations Plus initiated a collaboration to support the accelerated development of molnupiravir, a ribonucleoside analog with broad-spectrum activity against many RNA viruses. Molnupiravir is co-developed by Merck and Ridgeback Biotherapeutics and received emergency use authorizations in several countries including the US and the UK in late 2021. Register for MIDD+ to hear live from Merck & Cognigen scientists about how modeling activities contributed to the development of molnupiravir, and supported faster access to the patients affected by COVID-19:

• Use of exposure-response & immune-viral dynamics modeling to inform phase 3 evaluation of molnupiravir drug effect for COVID-19
• Population Pharmacokinetics for Molnupiravir in Adults with COVID-19

• Reserve your seat now for the Special Topics Course in Pharmacometric Methods on February 23rd & 24th.
• World Conference of Pharmacometrics – Register for a 2-Day Introductory Workshop In Population PK Data Analysis March 28th & 29th.

Contact the PMx Experts

North Carolina

DILIsym Services

SOT & ToxExpo Annual Meeting
Mar. 27-31, San Diego, CA
Spend March Madness with us at an informative Lunch & Learn+ event,
Winning Safety & Exposure Modeling Solutions with Brett Howell + John DiBella.

Scientific presentations include:

• Modeling of Indinavir-Induced Crystal Nephropathy in RENAsym presented by Pallavi Bhargava.
• Modeling of Cyclosporine A-Induced Acute Kidney Injury with RENAsym presented by Jeff Woodhead.
• QST Modeling of Cimaglermin Alfa (GGF2) Hepatotoxicity Shows the Potential of BIOLOGXsym to Predict Biologics-Induced Liver Injury (BILI) presented Brett Howell.
• Mechanistic Modeling of Biologics-Induced Liver Injury (BILI) Predicts Hepatotoxicity of Tocilizumab through Both On- and Off-Target Effects presented by Lara Clemens.
• Evaluating the Nephrotoxicity of Cisplatin in Rats with RENAsym, a Mechanistic Model of Drug-Induced Acute Kidney Injury presented by Nader Hamzavi.
• Simulating MDR3 Inhibition-Mediated Cholestatic Liver Injury Using DILIsym X, a QST Modeling Platform presented by James J. Beaudoin.

Speak with QST/QSP Experts

France

Lixoft

• Upgrade to MonolixSuite R2021 today!
• Stream the Feature of the Week video #124
• Hear Jonathan Chauvin present, “Therapeutic Drug Monitoring for Tyrosine Kinase Inhibitors. Possibilities, difficulties, and challenges” at MIDD+2022. Register here.
• Register for the 2022 Pharmacometrics Spring School!  Courses include:
  • Modeling & Simulation using MonolixSuite March 14-18
  • Non-compartmental analysis, bioequivalence and beyond Spring School with PKanalix March 22-24
• This year, stop by our booth at the QSPC Conference, April 20-22.

Follow Us on LinkedIn

Will we see YOU there?

Join your peers at MIDD+

Only 2 more weeks until MIDD+ 2022!

FREE MIDD+ Tickets